A record of what Sneha Poddar said publicly, with the source. Not advice.
Pending — not yet graded
“Bearish on the Pharma sector in the near term, expecting time correction due to high valuations, especially for CDMO players that have already seen a significant run-up, and ongoing uncertainty regarding tariff announcements. However, any correction or extended consolidation would present long-term accumulation opportunities for CDMO players like Laurus Labs, Biocon, and Divi’s, given their strong pipelines and global opportunities.”
Sneha Poddar’s track record (trackable calls only): 5 graded calls · 95% CI 4–62%
Nifty PharmaBearishCalled 21 Aug 2025
This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.
Read the original articleSee Sneha Poddar’s full track record